Cross border healthcare simulation Rita Baeten, Senior policy - - PowerPoint PPT Presentation

cross border healthcare simulation
SMART_READER_LITE
LIVE PREVIEW

Cross border healthcare simulation Rita Baeten, Senior policy - - PowerPoint PPT Presentation

Cross border healthcare simulation Rita Baeten, Senior policy analyst, OSE Jeni Bremner, Director, EHMA Directive on the application of Patients Directive on the application of Patients rights in ights in Cross-Border Healthcare


slide-1
SLIDE 1

Cross border healthcare simulation

Rita Baeten, Senior policy analyst, OSE Jeni Bremner, Director, EHMA

slide-2
SLIDE 2

Directive on the application of Patients’ Directive on the application of Patients’ rights in ights in Cross-Border Healthcare Cross-Border Healthcare

Adopted in March 2011, to be implemented by

October 2013

Rules on reimbursement of care provided in

another Member State (< CJEU rulings)

Flanking measures: quality of care, information,

co-operation between Member States

slide-3
SLIDE 3

Understand the likely future impact of the

Directive in practice

Forecast potential issues Insights on potential bottlenecks and different

ways of resolving them

slide-4
SLIDE 4

5 groups of stakeholders

Patients Insurers/Purchasers (2X) Public authorities Healthcare Providers

6 EU countries

Belgium, France, Germany, The Netherlands,

Luxembourg, Spain

Movements of patients between them Different healthcare systems

slide-5
SLIDE 5

3 case studies Including key issues

Prior authorisation Rare diseases Interaction with Regulation 883/04 Information to patients Controlling inflows and outflows

Specific questions for each stakeholder group

slide-6
SLIDE 6

Conditions for reimbursement Tariffs and supplements Invoices Prior authorisation Information on treatment Information on reimbursement Language and translation Managing the health system

slide-7
SLIDE 7

Insurers/purchasers/public authorities

Insurers/purchasers/public authorities:

Same conditions as for care provided domestically

Healthcare providers

Healthcare providers:

Would not adapt treatment procedures to the

Would not adapt treatment procedures to the requirements of foreign insurers requirements of foreign insurers

slide-8
SLIDE 8

Providers

Providers: Would charge private tariffs Would charge private tariffs (not the “social insurance” tariffs)

Insurers

Insurers: Some would limit payments to the social insurance tariffs of the MS of treatment

slide-9
SLIDE 9

How can insurers know what care has exactly

been provided?

Burden of proof lies with the patient

Burden of proof lies with the patient

Some providers willing to adapt invoices, against

payment

slide-10
SLIDE 10

Request it may become the general rule

Request it may become the general rule

Patients: “to be on the safe side” Insurers: To specify reimbursement

Refusal if specific concerns on quality and

safety?

Who should check? How to check?

  • > Expected not to be applied in practice

Expected not to be applied in practice

slide-11
SLIDE 11

Who should provide information on treatment

  • ptions and quality and safety?

Patients

Patients: (treating and referring) doctor

Providers

Providers: National contact points

Who is accountable for provided information?

slide-12
SLIDE 12

Health insurers:

Health insurers:

Consider themselves as a crucial source of

information

Patients:

Patients:

Plead for an independent source of advice, health

insurers not always impartial

Decisions too complex, should be taken by

competent authorities (e.g. application of Regulation 883/04 or the Directive)

slide-13
SLIDE 13

Invoices, medical record, treatment options Who has to pay: Patient

Patient

Who is accountable ?

slide-14
SLIDE 14

Restricting high inflows?

Restricting high inflows?

Lack of information on number of foreign patients No legal basis Likely not to be applied in practice

Likely not to be applied in practice

Impact of European Reference Networks

Pressure to reimburse care with an EU label

Pressure to reimburse care with an EU label

Transparency on tariffs, invoices, costs Information on quality, prices

slide-15
SLIDE 15

Directive brings legal certainty on important

aspects

Pragmatic solutions likely whilst numbers remain

low

Spill overs into the national system Default position is that the patient is responsible We can expect that patients will only use the

We can expect that patients will only use the Directive when there is no alternative, better Directive when there is no alternative, better managed option managed option

slide-16
SLIDE 16

… And much more: Jelfs, E. and Baeten, R. Simulation on the EU Simulation on the EU Cross-Border Care Directive, Final Report Cross-Border Care Directive, Final Report, OSE, EHMA, AIM, 2012 http://www.ose.be/files/publication/2012/Cross BorderHealthcareSimulation_FinalRep_0905201 2.pdf